Abstract T MP8: The Thrive Score Strongly Predicts Outcomes in Patients Treated With the Solitaire Device in the Swift and Star Trials
| العنوان: | Abstract T MP8: The Thrive Score Strongly Predicts Outcomes in Patients Treated With the Solitaire Device in the Swift and Star Trials |
|---|---|
| المؤلفون: | Alexander Flint, Vitor Mendes Pereira, Elad I Levy, Jeff Saver, Tudor Jovin, David Liebeskind, Raul Nogueira, Reza Jahan, Sean Cullen |
| المصدر: | Stroke. 45 |
| بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2014. |
| سنة النشر: | 2014 |
| مصطلحات موضوعية: | Advanced and Specialized Nursing, Neurology (clinical), Cardiology and Cardiovascular Medicine |
| الوصف: | Introduction: The THRIVE score strongly predicts clinical outcome, mortality, and risk of thrombolytic hemorrhage in ischemic stroke patients, and performs similarly well in patients receiving IV tPA, endovascular stroke treatment (EST), or no acute treatment. We recently validated the performance of the THRIVE score in the TREVO-2 trial of a third generation EST device, the Trevo device Methods: We examined the relationship between THRIVE and clinical outcomes (good outcome [mRS 0-2] or death at 90 days) among patients in SWIFT and STAR. Receiver-Operator Characteristics (ROC) curve analysis was used to compare THRIVE score performance to other stroke prediction scores. Multivariable logistic regression was used to confirm the independence of THRIVE score from procedure-specific predictors (target vessel recanalization or device used in SWIFT) of outcome. Results: THRIVE score strongly predicted good outcome (Figure, A) and death (Figure, B) among patients treated with the Solitaire device in SWIFT and STAR (Mantel-Haenztel Chi-square test for trend P Conclusions: The THRIVE score strongly predicts clinical outcome and mortality in patients treated with the Solitaire device in the SWIFT and STAR trials. The lack of interaction between THRIVE and procedure-specific elements such as vessel recanalization or device choice supports the use of the THRIVE score as an a priori selection criterion in stroke clinical trials. |
| تدمد: | 1524-4628 0039-2499 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::b1aef8d675174c12dcf52a1f887ddcf6 https://doi.org/10.1161/str.45.suppl_1.tmp8 |
| رقم الأكسشن: | edsair.doi...........b1aef8d675174c12dcf52a1f887ddcf6 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15244628 00392499 |
|---|